Cover image

Nanotheranostics, the sister journal of Theranostics, is a multidisciplinary and fully open access journal. Currently, the journal does not charge any publication or submission fees (Platinum open access). Nanotheranostics publishes innovative and original basic, translational and clinical research reflecting the fields of nanomedicine, nanoimaging, drug and gene delivery, nanoelectronic biosensors, and related areas. 

Regular features include high quality research articles, reviews or mini-reviews, rapid communication of preliminary data on innovative research, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical studies or ethical issues of nanomedicine are also welcome. Timely reviews that provide updates on current applications and issues in nanomedicine and translational aspects of nanotheranostics and other topics are particularly welcome and will be given high priority.

Nanotheranostics employs a rigorous peer-review system, but also strives for rapid review turnaround times and is based on the same streamlined submission platform as Theranostics.

Recent Papers:


Graphic abstract

Research Paper
A lipo-polymeric hybrid nanosystem with metal enhanced fluorescence for targeted imaging of metastatic breast cancer
Tejaswini Appidi, Rajalakshmi P Sivasankaran, Shubham A. Chinchulkar, Paloma Patra, Kavipriya Murugaiyan, Bantal Veeresh, Aravind Kumar Rengan
Nanotheranostics 2024; 8(2): 239-246. doi:10.7150/ntno.92410
Abstract Full text PDF


Graphic abstract

Review
Recent Trends in Bio-nanomaterials and Non-invasive Combinatorial Approaches of Photothermal Therapy against Cancer
Nitisha Beniwal, Anamika Verma, Chandra Lekha Putta, Aravind Kumar Rengan
Nanotheranostics 2024; 8(2): 219-238. doi:10.7150/ntno.91356
Abstract Full text PDF


Graphic abstract

Review
Surface engineered nanohybrids in plasmonic photothermal therapy for cancer: Regulatory and translational challenges
Monalisha Debnath, Sujit Kumar Debnath, Mangal Vishnu Talpade, Shweta Bhatt, Prem Prakash Gupta, Rohit Srivastava
Nanotheranostics 2024; 8(2): 202-218. doi:10.7150/ntno.92639
Abstract Full text PDF


Graphic abstract

Research Paper
Chitosan nanoplatform for the co-delivery of palbociclib and ultra-small magnesium nanoclusters: dual receptor targeting, therapy and imaging
Abhishesh Kumar Mehata, Virendra Singh, Vikas, Prachi Srivastava, Biplob Koch, Manoj Kumar, Madaswamy S. Muthu
Nanotheranostics 2024; 8(2): 179-201. doi:10.7150/ntno.94364
Abstract Full text PDF


Graphic abstract

Research Paper
Integrable Magnetic Fluid Hyperthermia Systems for 3D Magnetic Particle Imaging
André Behrends, Huimin Wei, Alexander Neumann, Thomas Friedrich, Anna C. Bakenecker, Matthias Graeser, Thorsten M. Buzug
Nanotheranostics 2024; 8(2): 163-178. doi:10.7150/ntno.90360
Abstract Full text PDF


Graphic abstract

Research Paper
Biodegradable Nanocomposite of ZnS(Mn) Quantum Dots Immobilized Graphene Oxide for Bioimaging Applications
Pavithra Kurungottu, Midhun Ben Thomas, Mahesh M Lalitha, Prathiksha Ganesh, Divya Prakash Gnanadhas, Dipshika Chakravortty, Ashok M Raichur, Rajendra Kurapati
Nanotheranostics 2024; 8(2): 150-162. doi:10.7150/ntno.87536
Abstract Full text PDF PubMed PMC


Graphic abstract

Review
Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics
Samridhi, Aseem Setia, Abhishesh Kumar Mehata, Vishnu Priya, Aditi Pradhan, Pragya Prasanna, Syam Mohan, Madaswamy S Muthu
Nanotheranostics 2024; 8(2): 127-149. doi:10.7150/ntno.92184
Abstract Full text PDF PubMed PMC


Graphic abstract

Research Paper
Radioactive gold nanoparticles coated with BSA: A promising approach for prostate cancer treatment
Angélica Bueno Barbezan, Wilmmer Alexander Arcos Rosero, Daniel Vieira Perez, Maria Eduarda Zaganin Rigo, Giovana Dias da Silva, Alex Alves Rodrigues, Luís Fernando de Almeida, Fábio Fernando Alves da Silva, Andy González Rivera, Natanael Gomes da Silva, Emerson S. Bernardes, Carlos Alberto Zeituni, Maria Elisa C. M. Rostelato
Nanotheranostics 2024; 8(1): 112-126. doi:10.7150/ntno.91507
Abstract Full text PDF PubMed PMC

More ...

Editor-in-Chief:
Jonathan Lovell, PhD
Associate Professor, Biomedical Engineering
University at Buffalo, State University of New York

Nanotheranostics has been selected by The Literature Selection Technical Review Committee (LSTRC) for inclusion in MEDLINE, the prestigious index of U.S. National Library of Medicine.


Nanotheranostics is now indexed in the Web of Science, Biological Abstracts and BIOSIS Previews.


2021 impact score is 5.28, and h-Index is 20 based on information from Resurchify.
The most significant feature of translational point-of-care technology “Personalized biosensors” is that it can be done quickly and by clinical staff who are not trained in clinical laboratory sciences. Rapid test results can quickly give a doctor or other medical worker answers that can help them decide what to do or how to treat a patient. This is helpful almost everywhere, from the emergency room to a patient getting care at home. When a doctor meets a patient for the first time, during a flare-up of a known problem or when a new symptom shows up in a patient who is already being....
Indocyanine green (ICG) is one of the FDA-approved near infra-red fluorescent (NIRF) probes for cancer imaging and image-guided surgery in the clinical setting. However, the limitations of ICG include poor photostability, high concentration toxicity, short circulation time, and poor cancer cell specificity. To overcome these hurdles, we engineered a nanoconstruct composed of poly (vinyl pyrrolidone) (PVP)-indocyanine green that is cloaked self-assembled with tannic acid (termed as indocyanine green-based glow nanoparticles probe, ICG-Glow NPs) for the cancer cell/tissue-specific targeting. The....
Extracellular vesicles (EVs), such as exosomes, are nanovesicles that have received significant attention due to their ability to contain various molecular cargos. EVs found in biological fluids have been demonstrated to have therapeutic potential, including as biomarkers. Despite being extensively studied, a significant downfall in EV research is the lack of standardised protocol for its isolation from human biological fluids, where EVs usually exist at low densities. In this study, we tested two well-established EV isolation protocols, precipitation, and size exclusion chromatography (SEC), to....
Background: The objective of this study was to demonstrate that synchrotron K-edge subtraction tomography (SKES-CT) can simultaneously track therapeutic cells and their encapsulating carrier, in vivo, in a rat model of focal brain injury using a dual-contrast agent approach. The second objective was to determine if SKES-CT could be used as a reference method for spectral photon counting tomography (SPCCT). Methods: Phantoms containing different concentrations of gold and iodine nanoparticles (AuNPS/INPs) were imaged with SKES-CT and SPCCT to assess their performances. A pre-clinical study was performed....
Popup Image